Recommendation 3: In adults with CIC, the panel suggests the use of MgO over management without MgO (conditional recommendation, very low certainty of evidence certainty).

Implementation considerations The trials were conducted for 4 weeks, although longer term use is probably appropriate. The panel suggests starting at a lower dose, which may be increased if necessary. Avoid use in patients with renal insufficiency due to risk of hypermagnesemia.